paralleling tumor reduction with mitomycin c therapy , the splenic hematopoietic progenitor and colony-forming b-cells were reduced in tumor-bearing and tumor-free mice , thus compromising its therapeutic effectiveness .
C0037993
splenic
C0018957
hematopoietic